Danaher placed on ‘positive catalyst watch’ at Citi

Citi analyst Patrick Donnelly keeps a Buy rating on Danaher (DHR) with a $265 price target and placed the shares on a “90-day positive catalyst watch.” While the backdrop for tools remains variable, Citi is more constructive on Danaher, the analyst tells investors in a research note. The firm sees the company’s bioprocessing guidance of 6%-7% for Q1 as conservative and views its recent cost-out initiatives positively in diagnostics and in China.